A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 8, 2006, Pages 958-963

  Aquilina, Sue ^a   Dalmas, M ^b   Calleja, N ^c   Gatt, P ^a   Scerri, L ^a  

^a UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

^b Malta National Cancer Registry   (Malta)

^c Medical Statistics   (Malta)

Author keywords

Cutaneous malignant melanoma; Incidence; Survival

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALTA; MELANOMA; METASTASIS POTENTIAL; MORBIDITY; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE;

FEMALE; HUMANS; MALE; MALTA; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 33747355134     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01694.x     Document Type: Article

References (18)

1. Bevona C, Sober AJ. Melanoma incidence trends. Dermatol Clin 2002; 20: 589-595.
2. De Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40: 2355-2366.
3. Hall HI, Miller DR, Rogers JD et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999; 40: 35-42.
4. MacKie RM, Hole D, Hunter JA et al. Cutaneous malignant melanoma in Scotland: Incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. Br Med J 1997; 315: 1117-1121.
5. Vinceti M, Bergomi M, Borciani N et al. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1999; 9: 97-103.
6. Van der Rhee HJ, Van der Spek-Keijser LMT, Van Westering R et al. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980-95. Br J Dermatol 1999; 140: 463-467.
7. McMullen EA, Kee F, Patterson CC et al. Improved survival for melanoma in Northern Ireland: A comparison of two 5-year periods (1984-88 and 1994-98). Br J Dermatol 2004; 151: 587-593.
8. Sant M, Aareleid T, Berrino F et al. EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003; 14: v61-118.
9. Armstrong BK, English DR. Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention, 2nd edn. Oxford University Press, New York, 1996: 1282-1312.
10. Autier P, DoréJF. Influence of sun exposures during childhood and during adulthood on melanoma risk. Int J Cancer 1998; 77: 533-537.
11. Scerri L, Aquilina S, Amato Gauci A et al. Sun awareness and sun protection practices in Malta. J Eur Acad Dermatol Venereol 2002; 16: 47-52.
12. Burton RC, Armstrong BK. Recent incidence trends imply a non-metastasising form of invasive melanoma. Melanoma Res 1994; 4: 107-113.
13. Schmid-Wendtner MH, Baumert J, Eberle J et al. Disease progression in patients with thin cutaneous melanomas (tumour thickness =0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98. Br J Derm 2003; 149: 788-793.
14. Rees JL. The melanoma epidemic: Reality and artefact. BMJ 1996; 20: 137-138.
15. Melia J. Changing incidence and mortality from cutaneous malignant melanoma. BMJ 1997; 315: 1106-1107.
16. Van Der Esch EP, Muir CS, Nectoux J et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483-490.
17. Melia J, Frost T, Graham-Brown R et al. Problems with registration of cutaneous malignant melanoma in England. Br J Cancer, 1995; 72: 224-228.
18. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 1999; 135: 275-280.